Staff Login
Japanese
| English
Contact Us
List
Search
Browse
Registration
Statistics
Search
Home
List
Reference
Patent
Reference - List
When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
«
»
8 Hits
Search Condition : Filter (MeSH = Bone Density Conservation Agents / pharmacology)
Species
Resource
RRC ID
Title
Journal
Published
Link
Human and Animal Cells
J774.1(RCB2652)
,
THP-1(RCB1189)
66035
Etidronate down-regulates Toll-like receptor (TLR) 2 ligand-induced proinflammatory cytokine production by inhibiting NF-κB activation.
Pharmacol Rep
2017-8-1
Pubmed
Full text
Zebrafish
RIKEN WT
64813
Effects of anti-osteoporosis drugs against dexamethasone-induced osteoporosis-like phenotype using a zebrafish scale-regeneration model.
J Pharmacol Sci
2020-6-1
Pubmed
Full text
Human and Animal Cells
HL60(RCB0041)
,
U-937 DE-4(RCB0435)
61871
Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway.
Biochem Pharmacol
2013-1-15
Pubmed
Full text
Human and Animal Cells
MC3T3-E1(RCB1126)
59723
Anti-Osteoporotic Effects of Kukoamine B Isolated from
Lycii Radicis
Cortex Extract on Osteoblast and Osteoclast Cells and Ovariectomized Osteoporosis Model Mice.
Int J Mol Sci
2019-6-6
Pubmed
Full text
Human and Animal Cells
RAW 264(RCB0535)
51636
NF-κB pathway inhibition by anthrocyclic glycoside aloin is key event in preventing osteoclastogenesis in RAW264.7 cells.
Phytomedicine
2016-4-15
Pubmed
Full text
Human and Animal Cells
MC3T3-E1(RCB1126)
37038
Encapsulated boron as an osteoinductive agent for bone scaffolds.
J Trace Elem Med Biol
2015-1-1
Pubmed
Full text
Human and Animal Cells
ST2(RCB0224)
,
MLC-6(RCB1536)
19332
Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells.
Anticancer Res
2009-4-1
Pubmed
DNA material
AxCA Luc+ (RDB02453)
11017
Identification of dynamin-2-mediated endocytosis as a new target of osteoporosis drugs, bisphosphonates.
Mol Pharmacol
2010-2-1
Pubmed
Full text